News
Natoli Engineering's Precision CT Scan allows manufacturers to visualize internal tablet structures without cutting or ...
Körber’s Business Area Pharma now offers a standardized approach to connect systems and equipment to its market-leading PAS-X ...
Almac Clinical Services has completed a multi-million-dollar investment to enhance cold chain capabilities at its global ...
Pace Life Sciences LLC is remodeling and expanding its Salem, NH, site to establish a Center of Excellence for Aseptic ...
Circio Holding ASA, a biotechnology company developing circular RNA technology for next generation nucleic acid medicine, has ...
The CDMO has increased its capacity by acquiring and installing a new, fully Annex 1 compliant, sterile filling line. As a ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Fujifilm’s FF-10832, an investigational liposomal formulation of gemcitabine, for the treatment of biliary tract ...
Biosynth, a developer and supplier of critical raw materials and services for life sciences and diagnostics, has opened an expanded GMP bioconjugation facility at its existing Berlin site.
Vetter, a global Contract Development and Manufacturing Organization (CDMO), has begun construction of its new clinical ...
The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data ...
Veranova has appointed Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides. Villain brings extensive ...
Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results